Senolytics
I've just finished my third Senolytic cycle.
Fisetin 1500 mgs on 2 consecutihve days repeated one month later
Dasatinab 180 mgs on 2 consecutive days + Quercitn 2250 mgs on the same days
I also take 4 mgs of Rapamycin once a week and 500 mgs of MetforminER twice a day.
65 years young.
-
Charles Grashow
that is fantastic your massage ! First time I find in internet this direct link between androgen dificiency and senolitic therapy. I was diagnosed 3 years ago with age related androgen dificiency. The doctor prescribe me trt . I was using gel patch and now I am near 1-2 year on nebido inj for every 12 weeks. During last 3 months I start only with fisetin Mayo Clinic protocol and made it 2 times. And this really so curiosity for me - that is already pass 16 weeks from the last inj and my testosterone level do not go down. I was doing blood analysis every week in a different labs, think that it might be the mistake. With androgen dificiency right level of testosterone is crucial important for me just to have a normal living and normal work. I depends very much from trt. Before trt my testosterone level was going down bellow then 250 ng/dL if I don’t use trt. Also long time of trt suppressing of my own body production of testosterone.
And now I do not to know what to do - stop trt or to continue any way? Because now my level is not ideal, is suboptimal (near 450 ng/dL). And I feel not enough..Could you clarify little bit more how you could discontinue use of trt. How long you use senolitic to stop trt? How do you stop, immediately or any way continue some time with injection? How much in dynamics your testosterone level change?
-
As a rapamycin and metformin user, I'm unsure if senolytics will offer additional advantage when combined with mtor inhibition. The main reason for doubt is that in vivo tissue studies of mice (hepatic) and human (skin fibroblast) indicate rapamycin appears to produce a relative "clearance" of sensence as opposed to just inhibition of SASP and slowing senescent conversion. BiogerontologyJune 2019, Volume 20, Issue 3, pp 331–335, GeroScienceDecember 2019, Volume 41, Issue 6, pp 861–869|
Most impressively, the study of human skin showed probable clearance of senescent cells (by biopsy and staining) using a topical .001% rapamycin applied daily or every other day for 8 months. This concentration is like taking one milligram tablet rapamycin, crushing it, and mixing it with about 3.5 ounces (100 grams) of your favorite moisturizer.
It does appear that combining multiple anti-aging therapies can produce additive results such as the fruit fly study combining rapamycin, trimetinib and lithium Proceedings of the National Academy of Sciences, 2019; 201913212 DOI: 10.1073/pnas.1913212116. However, this drug combination affects the nutrient sensing network via three separate pathways which logically could be expected to be additive.
The issue with rapamycin combined with senolytics is: if rapamycin serves to clear senesence, then the addition of a senolytic therapy may not provide that much additional benefit. I have not seen any study which answers this question as it would require a rodent group with rapa, a rodent group with senolytics (and controls) and a combined rapa/senolytic group. Has anyone seen such a study?
-
Metformin is taken along with rapamycin to counteract some of the metabolic effects such as insulin resistance. I have no idea (nor does anyone) if the combo of these two drugs will be synergistic in terms of additive years to human life span.
Yes, genetically modifying the worm genome to manipulate insulin signaling and mtor systems lead to a 500% lifespan increase vs an expected 130%. Both of these pathways are distinct although perhaps somewhat convergent as they are separate parts of a nutrient sensing network. This synergy has also been shown in the fruit fly experiment by combining lithium (insulin signaling), rapamycin (mtor), and a tyrosine kinase inhibitor, all distinct paths of the nutrient sensing network showing a synergistic lifespan extension.
In the case of rapamycin combined with senolytics, they are both doing much of the same thing - decreasing senescent cellular burden. Much of the benefit of each may be acting on exactly the same endpoint and therefore not particularly additive. Study of this could be done as illustrated in a previous post.
For what it is worth, my opinion is that people using rapamycin at an appropriate dose earlier in life (pre-disease) will have markedly less senesence with aging. For those who are already progressed into the disease of aging without treatment, senscent burden will likely be higher. I surmise that people who start treatment later have greater probability of benefit from senolytics while those who have limited senscent burden (earlier treaters) will not benefit as much.
We don't know too much at this time so this seems logical - and this logic affects my personal decisions on my own treatments. Opinions like mine are not worth much until proven or disproven with the scientific method but it is all we can go on sometimes.
-
From Dr Greens website
In a 2018 paper Blagosklonny states, "It has been calculated than rapamycin slows geroconversion by approximately 3-fold". This means rapamycin slows formation of senescent cells three-fold. [5]
it seems that if true rapamycin is not getting rid of older senescent cells, just slowing progression of accumulation of new ones.
I would interpret that to indicate another method is needed to rid old cells. I suppose if you start rapamycin young enough then a senolytic treatment is not needed
-
I’m currently starting my first Dasatinib (compounded generic formula) - 100mg + quecertin (1,000mg) In split doses for 3 days prescribed by Dr. Green. This is in addition to my weekly Rapa (6mg), candasartan (16mg daily), and tadalafil (5mg daily). Dr. Green is following a similar regimen. He only prescribed me one course of treatment and wants to see labs 2 weeks post treatment. He feels this senolytics treatment is complementary to my other meds. This is somewhat consistent with Mikhail Blagoskonny’s research although he has recently posted on twitter that the senolytics research is much weaker. Dr. Green’s formulation of D+Q for 3 days is similar to a recent human study that showed some positive results for a small study. After day 1 I haven’t really had any side effects except for a slight headache towards the end of day 1.